| View |
|
DR-XY48589
|
Sitagliptin (as phosphate monohydrate)
|
Torsit 100
|
100 mg
|
Film-Coated Tablet
|
-
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
30 January 2023
|
30 January 2028
|
| View |
|
DR-XY48590
|
Rivaroxaban
|
None
|
15 mg
|
Film-Coated Tablet
|
-
|
Beker Laboratories
|
Algeria
|
Initial
|
31 January 2023
|
31 January 2028
|
| View |
|
DR-XY48591
|
Sitagliptin (as phosphate monohydrate)
|
Sitatin 50
|
50 mg
|
Film-Coated Tablet
|
-
|
Rhydburg Pharmaceuticals Limited.
|
India
|
Initial
|
31 January 2023
|
31 January 2028
|
| View |
|
DR-XY48592
|
Sitagliptin (as phosphate monohydrate)
|
Sitatin 100
|
100 mg
|
Film-Coated Tablet
|
-
|
Rhydburg Pharmaceuticals Limited
|
India
|
Initial
|
31 January 2023
|
31 January 2028
|
| View |
|
DR-XY48593
|
Palbociclib
|
Palvored 125
|
125 mg
|
Capsule
|
-
|
Dr. Reddy's Laboratories Ltd. (Formulation FTO-7)
|
India
|
Monitored Release
|
01 February 2023
|
01 February 2026
|
| View |
|
DR-XY48594
|
Omeprazole (As Sodium)
|
Aezec
|
40mg
|
Lyophilized Powder for Injection (IV)
|
-
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
Initial
|
01 February 2023
|
01 February 2028
|
| View |
|
DR-XY48595
|
Multivitamins + Iron
|
Combiver
|
N/A
|
Capsule
|
-
|
Vonwelt, Inc.
|
Philippines
|
Initial (OTC)
|
02 February 2023
|
02 February 2026
|
| View |
|
DR-XY48596
|
Doxofylline
|
Maxivent
|
400 mg
|
Tablet
|
Drug for Obstructive Airway Disease (Xanthine)
|
Ajanta Pharma Limited
|
India
|
Initial
|
02 February 2023
|
02 February 2028
|
| View |
|
DR-XY48597
|
Palbociclib
|
Palvored 100
|
100 mg
|
Capsule
|
-
|
Dr. Reddy's Laboratories Ltd. (Formulation FTO-7)
|
India
|
Monitored Release
|
02 February 2023
|
01 February 2026
|
| View |
|
DR-XY48598
|
Palbociclib
|
Palvored 75
|
75 mg
|
Capsule
|
-
|
Dr. Reddy's Laboratories Ltd. (Formulation FTO-7)
|
India
|
Monitored Release
|
02 February 2023
|
02 February 2026
|
| View |
|
DR-XY48599
|
Dapagliflozin + Metformin Hydrochloride (in extended-
release form)
|
Dapzin -M 10 Forte
|
10mg/1 g
|
Film-Coated Tablet
|
-
|
Micro Labs Limited
|
India
|
Monitored Release (Re-Application)
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48600
|
Dapagliflozin + Metformin Hydrochloride (in extended-
release form)
|
Dapzin-M 10
|
10 mg/500 mg
|
Film-Coated Tablet
|
-
|
Micro Labs Limited
|
India
|
Monitored Release (Re-Application)
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48601
|
Dapagliflozin + Metformin Hydrochloride (in extended-
release form)
|
Dapzin-M 5 Forte
|
5 mg/1 g
|
Film-Coated Tablet
|
-
|
Micro Labs Limited
|
India
|
Monitored Release (Re-Application)
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48602
|
Dapagliflozin + Metformin Hydrochloride (in extended-
release form)
|
Dapzin-M 5
|
5 mg /500 mg
|
Tablet
|
-
|
Micro Labs Limited
|
India
|
Monitored Release (Re-Application)
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48603
|
Ascorbic Acid
|
None
|
500 mg
|
Capsule
|
-
|
Northfield Laboratories Inc.
|
Philippines
|
Initial (OTC)
|
06 February 2023
|
06 February 2028
|
| View |
|
DR-XY48604
|
Ascorbic Acid
|
None
|
500 mg
|
Tablet
|
-
|
Northfield Laboratories Inc.
|
Philippines
|
Initial (OTC)
|
06 February 2023
|
06 February 2028
|
| View |
|
DR-XY48605
|
Apixaban
|
Torapix 5
|
5mg
|
Film-Coated Tablet
|
-
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48606
|
Apixaban
|
Torapix 2.5
|
2.5mg
|
Film-Coated Tablet
|
-
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48607
|
Rivaroxaban
|
Xarelto
|
20 mg
|
Film-Coated Tablet
|
-
|
Bayer Bitterfeld GmbH
|
Germany
|
Initial
|
08 February 2023
|
08 February 2028
|
| View |
|
DR-XY48608
|
Rivaroxaban
|
Xarelto
|
15 mg
|
Film-Coated Tablet
|
-
|
Bayer Bitterfeld GmbH
|
Germany
|
Initial
|
08 February 2023
|
08 February 2028
|